Sanofi India Ltd.

Financial

	Sanofi India	Caplin Point Lab	Procter&Gamble Healt
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	1.7 %	n/a	20.1 %
Unclassified
R&D as a % of Total Sales	0.0	4.6 %	n/a
Financials
5 yr Average ROE	52.02 %	20.61 %	30.46 %
5yr average Equity Multiplier	4.62	1.17	2.99
5yr Average Asset Turnover Ratio	0.47	0.72	0.57
5yr Avg Net Profit Margin	24.38 %	24.8 %	17.93 %
Price to Book	14.86	5.3	19.17
P/E	30.94	28.17	34.24
5yr Avg Cash Conversion Cycle	4.83 Days	79.85 Days	-158.56 Days
Inventory Days	66.8 Days	64.55 Days	36.98 Days
Days Receivable	31.98 Days	100.92 Days	29.14 Days
Days Payable	63.37 Days	74.04 Days	177.2 Days
5yr Average Interest Coverage Ratio	906.11	579.71	337.3
5yr Avg ROCE	27.19 %	25.27 %	19.93 %
5yr Avg Operating Profit Margin	24.71 %	30.87 %	24.91 %
5 yr average Debt to Equity	0.0	0.01	0.0
5yr CAGR Net Profit	31.63 %	16.28 %	-4.58 %
5yr Average Return on Assets	11.5 %	17.7 %	10.24 %
Shareholdings
Promoter Holding	60.4 %	70.56 %	51.82 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	1.68 %	0.0
Change in Mutual Fund Holding (3 Yrs)	1.2 %	0.87 %	4.04 %

Business

	Sanofi India	Caplin Point Lab	Procter&Gamble Healt
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Branded Generic 0 Generic 0	Product Wise Break-Up Formulations 75.0 Pharmaceutical 0 Branded Generics 25.0	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 38.81 Cardiac Science 17.42 Respiratory Systems 13.48 Gastro Intestinal 10.56 Pain Management 7.15 Central Nervous System (CNS) 6.86 Anti-Infective 5.72 DERMA 0 VMN 0	-	-
Location Wise Break-Up	Location Wise Break-Up India 79.71 Singapore 20.29 USA 0 Africa 0 LATAM 0 International 0 Domestic 0	Location Wise Break-Up India 0 Latin America 76.0 USA 18.0 International 0 Singapore 0 Domestic 0 Africa 6.0	Location Wise Break-Up India 0 LATAM 0 USA 0 International 8.04 Singapore 0 Domestic 91.96 Africa 0